Article info

Sitagliptin versus mitiglinide switched from mealtime dosing of a rapid-acting insulin analog in patients with type 2 diabetes: a randomized, parallel-group study

Authors

  1. Correspondence to Dr Toshinari Takamura; ttakamura{at}m-kanazawa.jp
View Full Text

Citation

Takeshita Y, Takamura T, Kita Y, et al
Sitagliptin versus mitiglinide switched from mealtime dosing of a rapid-acting insulin analog in patients with type 2 diabetes: a randomized, parallel-group study

Publication history

  • Received June 9, 2015
  • Revised July 14, 2015
  • Accepted July 20, 2015
  • First published August 28, 2015.
Online issue publication 
August 28, 2015
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.